STOCKHOLM, SWEDEN (UroToday.com) - Presented by Karl-Dietrich Sievert,1 Christopher Chapple,2 David Sussman,3 Sidney Radomski,4 Peter Sand,5 Steven Guard,6 Christopher Nardo,7 Jihao Zhou,8 Victor Nitti9 at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
1University of Tuebingen, Tuebingen, Germany; 2Royal Hallamshire Hospital, Sheffield, UK; 3NJ School of Osteopathic Medicine, Newark, NJ, USA; 4University of Toronto, Toronto, ON, Canada; 5University of Chicago, Chicago, IL, USA; 6Allergan, Ltd., Marlow, UK; 7Allergan, Inc., Irvine, CA, USA; 8Allergan, Inc., Bridgewater, NJ, USA; 9New York University, New York, NY, USA